How many 3 filings has Seaport Therapeutics, Inc. filed?

Seaport Therapeutics, Inc. (SPTX) has 12 3 (3) filings on record, spanning May 2026.

A 3 is an SEC filing known as "3." It is filed with the SEC as a 3.

Where can I read Seaport Therapeutics, Inc. 3 filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Seaport Therapeutics, Inc. 3 filings, including risk assessment, sentiment analysis, and key financial figures.

Seaport Therapeutics, Inc. (SPTX) — 3 Filings

All 3 filings from Seaport Therapeutics, Inc.. Browse 12 3 reports with AI-powered summaries and risk analysis.

3 Filings (12)

Seaport Therapeutics Files Initial Ownership Statement — May 1, 2026 Risk: low
On April 30, 2026, Seaport Therapeutics, Inc. filed a Form 3, an initial statement of beneficial ownership of securities. This filing indicates the initial repo
Seaport Therapeutics Files Initial Ownership Statement — May 1, 2026 Risk: low
On April 30, 2026, Seaport Therapeutics, Inc. filed an initial statement of beneficial ownership of securities (Form 3). The filing was made by Zohar Daphne, a
Seaport Therapeutics Files Initial Ownership Statement — May 1, 2026 Risk: low
On April 30, 2026, Seaport Therapeutics, Inc. filed a Form 3, an initial statement of beneficial ownership of securities. This filing indicates the initial repo
Seaport Therapeutics Files Initial Ownership Statement — May 1, 2026 Risk: low
On April 30, 2026, Seaport Therapeutics, Inc. filed a Form 3, an initial statement of beneficial ownership of securities. This filing indicates changes in the o
3 Filing — May 1, 2026
Seaport Therapeutics Files Initial Ownership Statement — May 1, 2026 Risk: low
On April 30, 2026, Seaport Therapeutics, Inc. filed a Form 3, an initial statement of beneficial ownership of securities. This filing indicates the initial repo
Seaport Therapeutics Files Initial Ownership Statement — May 1, 2026 Risk: low
On April 30, 2026, Seaport Therapeutics, Inc. filed a Form 3, an initial statement of beneficial ownership of securities. David E. Wheadon, with CIK 0001789507,
Seaport Therapeutics Files Initial Ownership Statement — May 1, 2026 Risk: low
On April 30, 2026, Seaport Therapeutics, Inc. filed an initial statement of beneficial ownership of securities (Form 3). This filing pertains to the company's s
3 Filing — May 1, 2026
Seaport Therapeutics Files Initial Ownership Statement — May 1, 2026 Risk: low
On April 30, 2026, Seaport Therapeutics, Inc. filed a Form 3, indicating an initial statement of beneficial ownership of securities. The filing lists several in
Seaport Therapeutics Files Initial Ownership Statement — May 1, 2026 Risk: low
On April 30, 2026, Seaport Therapeutics, Inc. filed a Form 3, an initial statement of beneficial ownership of securities. Robert J. Hombach, with CIK 0001496182
3 Filing — May 1, 2026

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX